Is it time to tailor treatments in androgen receptor positive salivary gland cancers?

Paolo Bossi,Luigi Lorini,Deborah Cosentini,Salvatore Grisanti,Simonetta Battocchio,Alfredo Berruti

Oral Oncology（2023）

引用 0|浏览1

暂无评分

摘要

•Enzalutamide has a promising activity in preselected androgen receptor positive salivary gland carcinomas.•In castration sensitive patients, high testosterone levels may hindered enzalutamide activity.•Molecular and different phenotypic selection of androgen receptor positive salivary gland carcinomas may lead to tailor treatment for such patients.

查看译文

关键词

positive salivary gland cancers,androgen receptor,treatments

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要